sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiski līdzekļi - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
atorvastatin accord 20 mg apvalkotās tabletes
accord healthcare b.v., netherlands - atorvastatīns - apvalkotā tablete - 20 mg
atorvastatin accord 10 mg apvalkotās tabletes
accord healthcare b.v., netherlands - atorvastatīns - apvalkotā tablete - 10 mg
meropenem accord 1 g pulveris injekciju/infūziju šķīduma pagatavošanai
accord healthcare b.v., netherlands - meropenēms - pulveris injekciju/infūziju šķīduma pagatavošanai - 1 g
montelukast accord 10 mg apvalkotās tabletes
accord healthcare b.v., netherlands - montelukasts - apvalkotā tablete - 10 mg
olmesartan medoxomil accord 10 mg apvalkotās tabletes
accord healthcare b.v., netherlands - olmesartāna medoksomils - apvalkotā tablete - 10 mg
solifenacin accord 10 mg apvalkotās tabletes
accord healthcare b.v., netherlands - solifencīna sukcināts - apvalkotā tablete - 10 mg
olmesartan medoxomil accord 20 mg apvalkotās tabletes
accord healthcare b.v., netherlands - olmesartāna medoksomils - apvalkotā tablete - 20 mg
solifenacin accord 5 mg apvalkotās tabletes
accord healthcare b.v., netherlands - solifencīna sukcināts - apvalkotā tablete - 5 mg
olmesartan medoxomil accord 40 mg apvalkotās tabletes
accord healthcare b.v., netherlands - olmesartāna medoksomils - apvalkotā tablete - 40 mg